Nuvalent
Lisa Morelli currently serves as the Associate Director of Clinical Operations at Nuvalent, Inc., starting in October 2023. Prior to this role, Lisa held various positions in clinical project management and operations, including Clinical Research Project Manager at Clinical Resource Solutions, Inc. from January 2019 to November 2023, and Clinical Operations Consultant at Spero Therapeutics from August 2018 to February 2023. Experience includes significant contract roles at Verastem Oncology, Infinity Pharmaceuticals, and Enanta Pharmaceuticals, where responsibilities encompassed overseeing the first-in-human study for the Hepatitis C population. Additional roles spanned late phase research management at HealthCore, Inc., and senior clinical trial management at Atrium Medical Corporation. Lisa holds a Bachelor of Arts in English from the University of New Hampshire-Manchester.
This person is not in any teams
This person is not in any offices
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.